Search company, investor...

Medicrea

Submit Your Analyst Briefing

medicrea.com

Stage

Acquired | Acquired

Valuation

$0000 

About Medicrea

Medicrea provides personalized spinal implants. It utilizes a proprietary big data software to 3D-print titanium implants, specific to the patient's body.On July 15, 2020, Medicrea was acquired by Medtronic million.

Headquarters Location

50 Greene St Fl Fifth

New York, New York,

United States

646 490 2360

Missing: Medicrea's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Medicrea's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Medicrea

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Medicrea is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

11,779 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

7,901 items

Medicrea Patents

Medicrea has filed 69 patents.

The 3 most popular patent topics include:

  • Orthopedic surgical procedures
  • Bones of the vertebral column
  • Skeletal system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/19/2019

12/14/2021

Bones of the vertebral column, Spinal nerves, Bones of the thorax, Orthopedic surgical procedures, Skeletal system

Grant

Application Date

12/19/2019

Grant Date

12/14/2021

Title

Related Topics

Bones of the vertebral column, Spinal nerves, Bones of the thorax, Orthopedic surgical procedures, Skeletal system

Status

Grant

Latest Medicrea News

Our Employee Moved to California During the Pandemic, Can We Enforce Their Non-Compete? Choice of Law Analysis Will Matter

Feb 21, 2022

To embed, copy and paste the code into your website or blog: <iframe frameborder="1" height="620" scrolling="auto" src="//www.jdsupra.com/post/contentViewerEmbed.aspx?fid=1ec3a60f-08db-4acf-93bc-e368a57b80b7" style="border: 2px solid #ccc; overflow-x:hidden !important; overflow:hidden;" width="100%"></iframe> Many employers have granted their white collar workers increased flexibility to work remotely in response to the pandemic. As a result, some employees have moved away from the areas surrounding their offices and into places with lower costs or higher quality of living. In cases where an employee with a non-compete moves to a state such as California, which has a prohibition against any “contract by which anyone is restrained from engaging in a lawful profession, trade, or business of any kind,” that can present potential problems for a Company. Cal. Bus. & Prof. Code. § 16600. Medtronic, Inc. v. Walland, No. 21 CIV. 2908 (ER), 2021 WL 4131657, at *2 (S.D.N.Y. Sept. 10, 2021) explored that very issue when Medtronic, sought a preliminary injunction against Joseph Walland (“Walland”) the former CEO of company it had acquired, Medicrea. In denying a preliminary injunction preventing Walland from working for a competitor, the United States District Court for the Southern District of New York applied California law through a choice of law analysis and refused to enforce the non-compete provision in Walland’s employment agreement (“Agreement”). Walland was hired by Medicrea in 2017 as VP of sales, while living in California. He was promoted to CEO in 2018, and he alleged that he negotiated his CEO employment agreement while living in California. The Agreement stated in pertinent part that it “shall be governed by and construed under the laws of the State of New York, without regard to its conflict of laws principles.” The Agreement contained a non-compete provision whereby Walland agreed not to compete directly or indirectly for twelve months after separation from employment with any “competitive business” – in this case a business in the marketing and sale of spinal implants. After executing the Agreement, Walland moved to New York in 2018, and presided over Medicrea as CEO until he resigned in December of 2020, having moved back to California in March of 2020. In January 2021, Walland entered into a separation agreement (“Separation Agreement”) with Medtronic (which became the parent corporation of Medicrea in November 2020), wherein he specifically released any claims that the restrictive covenants in his Employment Agreement were unenforceable. By that time, however, Walland had already begun work for another company, Alphatec, which also sold spinal implant-related products. Medtronic then filed suit seeking an injunction preventing Walland from working for Alphatec. Upon an injunction application to the Court, the parties disagreed as to what law the court should apply. Medtronic argued New York law should apply. Walland, however, argued that “although contractual selection of governing law is generally determinative, courts will not adhere to such a selection where there is fraud, violation of public policy, or insufficient contacts between the State selected and the transaction.” The Court went on to hold that there was an actual conflict of law (regarding enforcement of non-compete provisions) that rendered a choice of law analysis necessary. Generally, New York courts will not enforce a choice-of-law provision where (1) the chosen law bears no reasonable relationship to the parties or the transaction or (2) where the chosen law violates some fundamental policy of a state that has a materially greater interest than does the chosen state. The court determined because Medicrea was headquartered in New York, and Walland lived and worked in New York for several years, there was a reasonable relationship between the New York choice of law, the parties and the “transaction” (in this case Walland’s employment). The Court held, however, that because Walland lived in California when he negotiated the Employment Agreement and because he currently lived there, California had a materially greater interest than New York. It went on to hold that the Agreement violates a fundamental public policy of California, insofar as it was a restriction on trade in violation of Cal. Bus. & Prof. Code. § 16600. The Court also held that Walland’s rights under Cal. Bus. & Prof. Code. § 16600 were not waivable, and thus, the Separation Agreement’s terms regarding waiver were likely unenforceable. Given that both agreements contained unenforceable terms that Medtronic sought to hold Walland to, the Court held that Medtronic was not likely to succeed on the merits, and thus denied the preliminary injunction. Medtronic v. Walland thus offers some guidance for a company considering entering into or seeking to enforce a non-compete against an employee who is working remotely from another state. Courts will consider factors such as the current locations of the employee and employer, the place(s) where the agreement was negotiated and executed, and whether there is a conflict between states’ laws where one state has a materially strong public policy regarding non-competes. As remote work appears here to stay in many industries, this is an issue that will likely continue to present itself in the coming years and employers are well-advised to seek legal advice when considering these issues.

Medicrea Frequently Asked Questions (FAQ)

  • Where is Medicrea's headquarters?

    Medicrea's headquarters is located at 50 Greene St, New York.

  • What is Medicrea's latest funding round?

    Medicrea's latest funding round is Acquired.

  • Who are the investors of Medicrea?

    Investors of Medicrea include Medtronic.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.